Sun, D., Rakesh, G., Haswell, C. C., Logue, M., Baird, C. L., O’Leary, E. N., Cotton, A. S., Xie, H., Tamburrino, M., Chen, T., Dennis, E. L., Jahanshad, N., Salminen, L. E., Thomopoulos, S. I., Rashid, F., Ching, C. R. K., Koch, S. B. J., Frijling, J. L., Nawijn, L., … Morey, R. A. (2022). A comparison of methods to harmonize cortical thickness measurements across scanners and sites. NeuroImage, 261, 119509. https://doi.org/10.1016/j.neuroimage.2022.119509

Zhang, L., Wang, Y., Schuemie, M. J., Blei, D. M., & Hripcsak, G. (2022). Adjusting for indirectly measured confounding using large-scale propensity score. Journal of Biomedical Informatics, 134, 104204. https://doi.org/10.1016/j.jbi.2022.104204

Ycaza, M., Keating, C., DiMango, E., Lopez, J., Saroya, T., & McNeill, T. (2022). 52 Participation in interventional drug trials of minority populations at an urban adult cystic fibrosis center. Journal of Cystic Fibrosis, 21, S32. https://doi.org/10.1016/s1569-1993(22)00743-3

Knox, J., & Curran, G. M. (2022). Merging lanes for science. Frontiers in Health Services, 2. https://doi.org/10.3389/frhs.2022.968175

Moran, A. E., Farrell, M., Cazabon, D., Sahoo, S. K., Mugrditchian, D., Pidugu, A., Chivardi, C., Walbaum, M., Alemayehu, S., Isaranuwatchai, W., Ankurawaranon, C., Choudhury, S. R., Pickersgill, S. J., Watkins, D. A., Husain, M. J., Rao, K. D., Matsushita, K., Marklund, M., Hutchinson, B., … Garg, R. (2022). Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries. Revista Panamericana de Salud Pública, 46, 1. https://doi.org/10.26633/rpsp.2022.140

Nguyen, D., Kandzari, D., El-Zein, R., Gosch, K., Kirtane, A., Yeh, R., Karmpaliotis, D., Spertus, J., Arnold, S., Grantham, J. A., & Salisbury, A. (2022). TCT-98 The Impact of Frailty on 1-Year Mortality After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease and Prohibitive Risk for Bypass Surgery. Journal of the American College of Cardiology, 80(12), B39. https://doi.org/10.1016/j.jacc.2022.08.118

Aschenbrenner, A. J., Hassenstab, J., Wang, G., Li, Y., Xiong, C., McDade, E., Clifford, D. B., Salloway, S., Farlow, M., Yaari, R., Cheng, E. Y. J., Holdridge, K. C., Mummery, C. J., Masters, C. L., Hsiung, G.-Y., Surti, G., Day, G. S., Weintraub, S., Honig, L. S., … Bateman, R. J. (2022). Avoid or Embrace? Practice Effects in Alzheimer’s Disease Prevention Trials. Frontiers in Aging Neuroscience, 14. https://doi.org/10.3389/fnagi.2022.883131

Yu, J. B. (2022). Fostering Transdisciplinary Collaborations in Cancer Health Economics Research. JNCI Monographs, 2022(59), 85–88. https://doi.org/10.1093/jncimonographs/lgac001

Bryan, A., Mobley, C., Moran, A., Derington, C., Zhang, Y., Rodgers, A., Shea, S., & Bellows, B. (2022). EE310 Cost-Effectiveness of Initiating Antihypertensive Therapy with Single-Pill Combinations Versus Monotherapy in US Adults. Value in Health, 25(7), S394. https://doi.org/10.1016/j.jval.2022.04.555

Maisel-Campbell, A., Schlessinger, D. I., Yanes, A. F., Veledar, E., Reynolds, K. A., Ibrahim, S. A., Kang, B. Y., Anvery, N., Poon, E., & Alam, M. (2022). Voting behavior during FDA Medical Device Advisory Committee panel meetings. PLOS ONE, 17(6), e0267134. https://doi.org/10.1371/journal.pone.0267134

Sahoo, S. K., Pathni, A. K., Krishna, A., Sharma, B., Cazabon, D., Moran, A. E., & Hering, D. (2022). ESTIMATES ON MEDICATION COST OF DRUG DOSE SPECIFIC TREATMENT PROTOCOL FOR HYPERTENSION MANAGEMENT IN PUBLIC AND PRIVATE HEALTHCARE SECTORS IN INDIA. Journal of Hypertension, 40(Suppl 1), e232. https://doi.org/10.1097/01.hjh.0000837844.63102.4a

Kohli-Lynch, C. N., Lewsey, J., Boyd, K. A., French, D. D., Jordan, N., Moran, A. E., Sattar, N., Preiss, D., & Briggs, A. H. (2022). Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease. Circulation, 145(17), 1312–1323. https://doi.org/10.1161/circulationaha.121.057631

Mazza, G. L., Petersen, M. M., Ginos, B., Langlais, B. T., Heon, N., Gounder, M. M., Mahoney, M. R., Zoroufy, A. J., Schwartz, G. K., Rogak, L. J., Thanarajasingam, G., Basch, E., & Dueck, A. C. (2021). Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2. Quality of Life Research, 31(4), 1069–1080. https://doi.org/10.1007/s11136-021-02968-1

Kostick-Quenet, K. M., Blumenthal-Barby, J., Mehra, M., Lang, B., Dorfman, N., Bhimaraj, A., Civitello, A., Jorde, U., Trachtenberg, B., Uriel, N., Kaplan, H., Gilmore-Szott, E., Volk, R., & Estep, J. (2022). Integrating Personalized Risk Scores in Decision Making About Left Ventricular Assist Device (LVAD) Therapy: Clinician and Patient Perspectives. The Journal of Heart and Lung Transplantation, 41(4), S230. https://doi.org/10.1016/j.healun.2022.01.1714

Yap, C., Solovyeva, O., Yin, Z., Martin, J., Manickavasagar, T., Weir, C., Lee, S., Dimairo, M., Liu, R., Kightley, A., & de Bono, J. S. (2022). 53P Assessing the reporting quality of early phase dose-finding trials. Annals of Oncology, 33, S24. https://doi.org/10.1016/j.annonc.2022.01.018

Kahn, J. M., Gray, D. M., Oliveri, J. M., Washington, C. M., DeGraffinreid, C. R., & Paskett, E. D. (2021). Strategies to improve diversity, equity, and inclusion in clinical trials. Cancer, 128(2), 216–221. Portico. https://doi.org/10.1002/cncr.33905

Parisien, R. L., Trofa, D. P., Cronin, P. K., Dashe, J., Curry, E. J., Eichinger, J. K., Levine, W. N., Tornetta, P., & Li, X. (2021). Comparative Studies in the Shoulder Literature Lack Statistical Robustness: A Fragility Analysis. Arthroscopy, Sports Medicine, and Rehabilitation, 3(6), e1899–e1904. https://doi.org/10.1016/j.asmr.2021.08.017

Al-Makki, A., DiPette, D., Whelton, P. K., Murad, M. H., Mustafa, R. A., Acharya, S., Beheiry, H. M., Champagne, B., Connell, K., Cooney, M. T., Ezeigwe, N., Gaziano, T. A., Gidio, A., Lopez-Jaramillo, P., Khan, U. I., Kumarapeli, V., Moran, A. E., Silwimba, M. M., Rayner, B., … Khan, T. (2022). Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary. Hypertension, 79(1), 293–301. https://doi.org/10.1161/hypertensionaha.121.18192

Carter, S. A., Lightstone, L., Cattran, D., Tong, A., Bagga, A., Barbour, S. J., Barratt, J., Boletis, J., Caster, D. J., Coppo, R., Fervenza, F. C., Floege, J., Hladunewich, M. A., Hogan, J. J., Kitching, A. R., Lafayette, R. A., Malvar, A., Radhakrishnan, J., Rovin, B. H., … Craig, J. C. (2022). A Core Outcome Set for Trials in Glomerular Disease. Clinical Journal of the American Society of Nephrology, 17(1), 53–64. https://doi.org/10.2215/cjn.07840621

Butala, N. M., Raja, A., Xu, J., Strom, J. B., Schermerhorn, M., Beckman, J. A., Shishehbor, M. H., Shen, C., Yeh, R. W., & Secemsky, E. A. (2021). Association of Frailty With Treatment Selection and Long‐Term Outcomes Among Patients With Chronic Limb‐Threatening Ischemia. Journal of the American Heart Association, 10(24). https://doi.org/10.1161/jaha.121.023138

Austin, J. D., Tehranifar, P., Rodriguez, C. B., Brotzman, L., Agovino, M., Ziazadeh, D., Moise, N., & Shelton, R. C. (2021). A mixed-methods study of multi-level factors influencing mammography overuse among an older ethnically diverse screening population: implications for de-implementation. Implementation Science Communications, 2(1). https://doi.org/10.1186/s43058-021-00217-7

Bajorek, L. P., Kiekhofer, R., Hall, M., Taylor, J., Lucente, D. E., Brushaber, D., Appleby, B., Coppolla, G., Bordelon, Y. M., Botha, H., Dickerson, B. C., Dickson, D. W., Domoto‐Reilly, K., Fagan, A. M., Fields, J. A., Fong, J. C., Foroud, T. M., Forsberg, L. K., … Galasko, D. R. (2021). Demographic and psychosocial factors associated with the decision to learn mutation status in familial frontotemporal dementia and the impact of disclosure on mood. Alzheimer’s & Dementia, 17(S7). Portico. https://doi.org/10.1002/alz.050692

Kohli-Lynch, C. N., Bellows, B. K., Zhang, Y., Spring, B., Kazi, D. S., Pletcher, M. J., Vittinghoff, E., Allen, N. B., & Moran, A. E. (2021). Cost-Effectiveness of Lipid-Lowering Treatments in Young Adults. Journal of the American College of Cardiology, 78(20), 1954–1964. https://doi.org/10.1016/j.jacc.2021.08.065

Powell, D. S., Kuo, P.-L., Qureshi, R., Coburn, S. B., Knopman, D. S., Palta, P., Gottesman, R., Griswold, M., Albert, M., Deal, J. A., & Gross, A. L. (2021). The Relationship of APOE ε4, Race, and Sex on the Age of Onset and Risk of Dementia. Frontiers in Neurology, 12. https://doi.org/10.3389/fneur.2021.735036

Matsumoto, H., & Snyder, B. (2021). Improving the Quality of EOS Clinical Research:A Step-by-Step Guide. Journal of the Pediatric Orthopaedic Society of North America, 3(4), 384. https://doi.org/10.55275/jposna-2021-384

Toscano, F., Vera, A., Kim, E., Golinelli, D., Vila-Reyes, H., Bteich, F., Schernberg, A., Seban, R.-D., Yeh, R., & Dercle, L. (2021). The Role of Cost-Effectiveness Analysis in Patient-Centered Cancer Care in the Era of Precision Medicine. Cancers, 13(17), 4272. https://doi.org/10.3390/cancers13174272